Company Filing History:
Years Active: 2000
Title: Samir Morris Henalla: Innovator in Medical Instrumentation
Introduction
Samir Morris Henalla is a notable inventor based in Barnsley, GB. He has made significant contributions to the field of medical instrumentation, particularly in the area of injectable materials for treating urinary conditions. His innovative approach has led to the development of a unique instrument that enhances the precision of medical procedures.
Latest Patents
Samir Morris Henalla holds a patent for an instrument designed to guide the delivery of injectable materials. This patent, titled "Instrument for guiding delivery of injectable materials in treating," describes an introducer that facilitates the injection of a bulking agent into the urinary sphincter. The instrument features a rigid tubular member with a closed distal end and an open proximal end, along with a lumen extending between them. The design includes an aperture in the side wall, which is strategically placed at a predetermined distance from the closed end. Additionally, the instrument incorporates a flared wall structure shaped like a hollow cone, with oblique bores that allow for precise needle placement.
Career Highlights
Samir Morris Henalla is associated with Uroplasty, Inc., a company that specializes in innovative solutions for urinary disorders. His work at Uroplasty has been instrumental in advancing medical technologies that improve patient outcomes. With a focus on enhancing the delivery of injectable materials, Henalla's contributions are paving the way for more effective treatments in urology.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Samir Morris Henalla's innovative work in medical instrumentation exemplifies the impact of creativity and engineering in healthcare. His patent for an instrument guiding the delivery of injectable materials showcases his commitment to improving medical procedures. Through his role at Uroplasty, Inc., he continues to contribute to advancements in the field, ultimately benefiting patients in need of effective treatments.